Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.72 USD | -2.61% | -3.20% | -24.19% |
May. 10 | UBS Adjusts Rocket Pharmaceuticals Price Target to $51 From $54, Maintains Buy Rating | MT |
May. 10 | Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise | MT |
Business Summary
Number of employees: 268
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 | |
Mayo Pujols
CTO | Chief Tech/Sci/R&D Officer | 55 | 22-07-26 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Brooks Rahmer
IRC | Investor Relations Contact | - | - |
Mark White
PRN | Corporate Officer/Principal | 57 | 23-04-03 |
Carlos Martin
PRN | Corporate Officer/Principal | - | - |
Isabel Carmona
HRO | Human Resources Officer | - | 21-09-06 |
Gayatri R. Rao
PRN | Corporate Officer/Principal | - | 18-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Rod Wong
CHM | Chairman | 47 | 17-12-31 |
Director/Board Member | 47 | 17-12-31 | |
Gotham Makker
BRD | Director/Board Member | 50 | 18-01-03 |
Fady Malik
BRD | Director/Board Member | 59 | 22-03-09 |
Director/Board Member | 63 | 20-04-19 | |
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
R. Woods
BRD | Director/Board Member | 57 | Dec. 11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,782,211 | 85,963,246 ( 94.69 %) | 0 | 94.69 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.19% | 2.06B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- RCKT Stock
- Company Rocket Pharmaceuticals, Inc.